Back to search

Article

A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture

2024-06-07

Abstract excerpt

Nanoparticle presentation systems offer the potential to develop new vaccines rapidly in response to emerging diseases, a public health need that has become increasingly evident in the wake of the COVID-19 pandemic. Previously, we reported a nanoparticle scaffold system termed VelcroVax. This was constructed by insertion of a high affinity SUMO binding protein (Affimer), able to recognise a SUMO peptide tag, into...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
21b1b539-0bc6-5297-aba5-83aca05abf57
DOI
10.1101/2024.06.07.597873
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen captureDOI 10.1101/2024.06.07.597873
Select a neighboring publication to make it the new centre.